MedPath

To assess the Skin sensitivity of Amrutanjan pain balm

Phase 4
Completed
Conditions
For testing skin irritation potential
Registration Number
CTRI/2023/03/051035
Lead Sponsor
Amrutanjan Health Care Limited, Tamil Nadu, India.
Brief Summary

The subjects who fulfilled the inclusion and exclusion criteria will be enrolled in the study. 12 healthy adult subjects will be divided into 2 arms with 6 in each. Six Subjects will be topically applying the pain balm of product A and six subjects will be topically applying Product B over forehead region and they will be in house for a period of 8 hours and monitored at 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs for clinical scores of erythema/dryness/wrinkles/oedema. Then a wash out period of 5 days is given. Patients with any erythema/ oedema will not be included for the Subsequent study procedure. Then, the subjects will be crossed over and the same procedures will be repeated. The following parameters will be assessed for each subject; Erythema/dryness/wrinkles Oedema Mean Irritation Index

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
12
Inclusion Criteria
  • 1.Patients of either sex aged above 18 years.
  • 2.Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.
Exclusion Criteria
  • 1.Past history of allergy, asthma and atopy.
  • 2.Known allergy to compounds of investigational product.
  • 3.Participation in an investigational drug trial in the 30 days prior to the screening visit.
  • 4.Patients of vulnerable group (children, lactating mother, elderly >80 years, handicapped, seriously ill, mentally challenged).
  • 5.Subjects with known history of Sinusitis, Migraine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The following parameters will be assessed for each subject;Time Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
3. Mean Irritation IndexTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
Scale: ReactionTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
1. Erythema/dryness/wrinklesTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
2. OedemaTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
1- Very slight erythema/dryness withshiny appearance/very slight oedemaTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
2 - Slight erythema/dryness/wrinkles/slight oedemaTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
Clinical score for Erythema/ Dryness/Wrinkles/oedema : scale 0-4Time Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
0- No reactionTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
3 - Moderate erythema/dryness/wrinkles/moderate oedemaTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
4 - Severe erythema/wrinkles/scales/severe oedemaTime Frame: Baseline (0 minute), 5 min., 15 min., 30 min., 1 hr, 2 hr, 4 hr, 6 hr and 8 hrs.
Secondary Outcome Measures
NameTimeMethod
Time to onset of skin irritation/burning sensation Time frame: 0-8 hrs post doseTime taken for complete relief of skin irritation/burning sensation.

Trial Locations

Locations (1)

Thirumalai Medical Centre, Puducherry

🇮🇳

Pondicherry, PONDICHERRY, India

Thirumalai Medical Centre, Puducherry
🇮🇳Pondicherry, PONDICHERRY, India
Dr M Sakthi Balan
Principal investigator
9443627722
saheerose@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.